ICON PLC (ICLR)
NASDAQ · Healthcare · Diagnostics & Research
ICON PLC is a Healthcare company with a market capitalization of $13.01B and a trailing P/E ratio of 74.5.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 27, 2026 | $1.93 | $3.12 | -38.1% |
| Q4 2025 | February 25, 2026 | $2.52 | $3.31 | -23.9% |
| Q3 2025 | October 22, 2025 | $3.31 | $3.28 | +0.9% |
| Q2 2025 | July 23, 2025 | $3.26 | $3.18 | +2.5% |
| Q1 2025 | April 30, 2025 | $3.19 | $3.09 | +3.2% |
| Q4 2024 | February 19, 2025 | $3.43 | $3.43 | +0.1% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is ICON PLC's market cap?
As of June 29, 2026, ICON PLC (ICLR) has a market capitalization of $13.01B.
What is ICON PLC's P/E ratio?
ICON PLC trades at a trailing price-to-earnings (P/E) ratio of 74.5. Its forward P/E is 16.3.
Does ICON PLC pay a dividend?
ICON PLC does not currently pay a dividend.
What sector is ICLR in?
ICON PLC is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was ICON PLC's revenue?
In its latest reported fiscal year (ending December 31, 2025), ICON PLC reported revenue of $8.25B and net income of $229.34M.
Ask your own questions about ICLR
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.